Educational & Research Use Only. Not medical advice. Compounds are research-grade and not FDA-approved unless explicitly noted.
03
Section 03 · 3 compounds

Inflammation & Immune-Modulated Repair

Balancing protective inflammatory responses without suppressing them.

Inflammation is not the enemy. It's the body's signal flare for damage and invasion. The peptides here aren't suppressors — they're modulators. They quiet the inflammation that has lost its purpose without weakening defenses that still serve the body.

Click any peptide below to expand. Each entry covers what it is, what it's being studied to do, why it matters, potential impact, and common research pairings, with quick facts in the sidebar.

Lysine-Proline-Valine · α-MSH C-Terminal Fragment

KPV is a three-amino-acid fragment (Lysine-Proline-Valine) derived from the C-terminal of alpha-melanocyte-stimulating hormone (α-MSH), a natural regulatory peptide. The full α-MSH molecule has both anti-inflammatory and pigmentation effects. KPV keeps the calming part and leaves the rest — a tightly focused signal for inflammation control.

What It's Being Studied To Do

  • Reduce pro-inflammatory cytokine signaling (e.g., NF-κB pathway suppression)
  • Support gut barrier integrity in inflammatory models
  • Modulate immune responses without broad suppression
  • Decrease overactivation in skin and mucosal tissues
  • Promote a balanced environment for healing

Why This Matters

Uncontrolled inflammation can damage joints, gut lining, skin, or delay recovery — turning protection into harm. KPV's targeted modulation explores restoring the body's designed "on/off" switch, allowing repair without collateral damage and improving comfort and function.

Potential Impact Being Explored

Reduced inflammatory markers, better gut and joint resilience, support in skin conditions, and an enhanced recovery environment when inflammation is properly controlled.

Common Research Pairings

BPC-157 · repair + modulationGHK-Cu · structural supportKLOW blend · comprehensive healing

GHK-Cu 50mg · BPC-157 10mg · TB-500 10mg

GLOW is a pre-formulated research blend that combines three of the most-studied regenerative peptides in fixed ratios: GHK-Cu (50 mg) for collagen stimulation and gene expression support, BPC-157 (10 mg) for vascular and connective tissue signaling, and TB-500 (10 mg) for cellular migration and structural remodeling. The combination is designed to target multiple overlapping phases of repair simultaneously rather than relying on a single mechanism.

The Symphony ApproachOne peptide is a soloist. Three working in their specific ratios is a small ensemble — each playing a different phase of the repair cascade so the whole performance lands.

What It's Being Studied To Do

  • Stimulate collagen and extracellular matrix production (via GHK-Cu)
  • Promote angiogenesis and connective tissue coordination (via BPC-157)
  • Enhance cell migration and cytoskeletal organization to injury sites (via TB-500)
  • Accelerate overall tissue remodeling
  • Reduce excessive fibrosis or disorganized scarring
  • Support more organized, functional healing in musculoskeletal, skin, and soft-tissue contexts

Why This Matters

Healing is rarely the result of one signal alone — successful recovery requires blood supply, structural protein synthesis, and cells moving into place at the right time. When any part lags due to age, poor circulation, or chronic stress, repair can be slow, incomplete, or leave behind weak or scarred tissue. GLOW research represents an effort to support the full symphony of repair pathways at once.

Potential Impact Being Explored

Improved skin quality and elasticity, faster musculoskeletal recovery after strain or injury, better connective tissue organization, reduced recovery time compared to single-peptide models, and more comprehensive structural resilience. Popular in regenerative research for its systems-level approach.

Common Research Pairings

KPV · inflammation balanceMOTS-C / NAD+ · cellular energyL-Carnitine · metabolic overlap

GHK-Cu 50mg · BPC-157 10mg · TB-500 10mg · KPV 10mg

KLOW is GLOW with a fourth voice added: KPV (10 mg), the anti-inflammatory α-MSH fragment. The result is a four-component research tool that addresses both structural repair and inflammatory balance in a single formulation — useful in models where lingering inflammation slows or distorts the healing process.

What It's Being Studied To Do

  • Synthesize collagen and extracellular matrix (GHK-Cu)
  • Form new blood vessels and improve nutrient delivery (BPC-157)
  • Recruit repair cells and organize tissue (TB-500)
  • Reduce excessive cytokine signaling and inflammatory overactivation (KPV)
  • Support gut barrier and joint integrity in inflammatory models
  • Facilitate a controlled, efficient healing environment that minimizes secondary damage

Why This Matters

Inflammation is a necessary first responder — but when it lingers, it can break down newly formed tissue, increase pain, and delay full recovery. Many people experience this cycle in joints, tendons, gut issues, or post-injury scenarios. KLOW research explores reinforcing the body's built-in ability to raise inflammation appropriately and then resolve it cleanly — restoring the natural rhythm of protection followed by restoration.

Potential Impact Being Explored

Enhanced joint and connective tissue comfort during recovery, improved skin remodeling outcomes, better resolution of inflammatory states in soft tissues, reduced risk of fibrotic buildup compared to structural-only blends, and a more balanced regenerative trajectory overall.

Common Research Pairings

MOTS-C / SS-31 · mitochondrial energyNAD+ / glutathione · oxidative protectionAOD-9604 · body composition overlap
← 02 · Repair, Regeneration & Structural Recovery 04 · Growth Hormone & Regenerative Axis →